D. A. S. Compston

Alemtuzumab versus interferon beta 1a as first-line treatment for patients with relapsing-remitting multiple sclerosis: a randomised controlled phase 3 trial

Jeffrey Cohen, Alasdair Coles, Douglas L. Arnold et al. · The Lancet · 2012 · 1.2K citations

Life Sciences, Immunology, Neurology +11

Alemtuzumab for patients with relapsing multiple sclerosis after disease-modifying therapy: a randomised controlled phase 3 trial

Alasdair Coles, Cary Twyman, Douglas L. Arnold et al. · The Lancet · 2012 · 1.2K citations · Full text

Life Sciences, Immunology, Neurology +11

Multiple Sclerosis Severity Score

Richard Roxburgh, Shaun R. Seaman, Thomas Masterman et al. · Neurology · 2005 · 955 citations

Medicine, Biostatistics, Neurology +17

Interleukin 7 receptor α chain ( IL7R ) shows allelic and functional association with multiple sclerosis

Simon G. Gregory, Silke Schmidt, Puneet Seth et al. · Nature Genetics · 2007 · 649 citations

Life Sciences, Immunology, Neurology +15

A genetic study of von Recklinghausen neurofibromatosis in south east Wales. I. Prevalence, fitness, mutation rate, and effect of parental transmission on severity.

Susan Huson, D. A. S. Compston, Peggy Clark et al. · Journal of Medical Genetics · 1989 · 544 citations · Full text

Life Sciences, Genetics, Molecular Genetics +17